After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Cara Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $0.80 and fluctuated between $0.8000 as its day high and $0.6817 as its day low. The current market capitalization of Cara Therapeutics Inc is $43.52M. A total of 1.2 million shares were traded on the day, compared to an average of 808.68K shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, CARA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 5 BUYs and 13 SELLs from insiders. Insiders purchased 194,172 shares during that period but sold 53,132.
In the most recent transaction, Posner Christopher sold 35,575 shares of CARA for 0.53 per share on Feb 08. After the transaction, the PRESIDENT AND CEO now owns 186,355 company shares. In a previous transaction on Feb 01, Posner Christopher sold 4,981 shares at 0.55 per share. CARA shares that PRESIDENT AND CEO owns now total 221,930.
Among the insiders who sold shares, Posner Christopher disposed of 3,796 shares on Nov 02 at a per-share price of $1.22. This resulted in the President and CEO holding 164,411 shares of CARA after the transaction. In another insider transaction, Posner Christopher sold 4,307 shares at $3.07 per share on Aug 03. Company shares held by the President and CEO now total 168,207.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for CARA in the last 3 months, the mean price target is $5.10 with high estimates of $11.00 and low estimates of $1.00. In terms of 52-week highs and lows, CARA has a high of $10.52 and a low of $0.50.
As of this writing, CARA has an earnings estimate of -$0.41 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.19 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.58 in the last quarter, which was -7.40% lower than expectations of -$0.54.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CARA’s latest balance sheet shows that the firm has $167.03M in Cash & Short Term Investments as of fiscal 2021. There were $3.67M in debt and $17.62M in liabilities at the time. Its Book Value Per Share was $1.57, while its Total Shareholder’s Equity was $227.52M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CARA is Buy with a score of 4.50.
